Your browser has 'Cookies' disabled, alert boxes will continue to appear without this feature.
Activity description

155841 - Driving Safety – Sedating Medications & Opioid Agonist Treatment

University of Sydney, Discipline of Addiction Medicine

Prescribers and health professionals caring for patients who receive opioid agonist treatment (OAT) need to be aware of the potential impact of treatments and other factors on driving safety.

For individuals receiving pharmacotherapy for the treatment of opioid dependence:

Driving or operating heavy machinery after dosing with methadone or buprenorphine is not associated with increased risk of accident or injury provided the patient is on a stable dose of the medication and is not using significant amounts of other psychoactive drugs (particularly alcohol, benzodiazepines or cannabis).

This short course is designed to support health professionals in assessing a patient’s fitness to drive, with a focus on sedating medications and OAT.

Relevance to General Practice

Driving a motor vehicle or operating heavy machinery is a complex task that requires sufficient sensory input, cognitive function, and motor function. A range of medical conditions, disabilities and treatments can impact on these tasks and may result in impairment. It is important that individuals and their health professionals are aware of the circumstances that makes someone unsuitable to drive, whether it be related to fitness to drive today, or fitness to hold a licence.

For individuals receiving pharmacotherapy for the treatment of opioid dependence:

Driving or operating heavy machinery after dosing with methadone or buprenorphine is not associated with increased risk of accident or injury provided the patient is on a stable dose of the medication and is not using significant amounts of other psychoactive drugs (particularly alcohol, benzodiazepines or cannabis).

[NSW Clinical Guidelines: Treatment of Opioid Dependence (2018)]

Learning outcomes

  1. Manage patient factors that can impact on driving safety & diagnose risks to driving, including for those receiving opioid agonist treatment (OAT).
  2. Implement principles of short-term fitness to drive and long-term medical fitness to drive into daily patient assessment and practice.
  3. Manage roles and responsibilities, confidentiality, and difficult clinical conversations to effectively manage patient fitness to drive for patients.
  4. Implement the medical standards for licensing and reporting legislation within New South Wales into practice.

Domains of General Practice

D1. Communication skills and the patient-doctor relationship
  • Communication is clear, respectful, empathic and appropriate to the person and their sociocultural context

D2. Applied professional knowledge and skills
  • The conduct of the consultation is appropriate to the needs of the patient and the sociocultural context

D3. Population health and the context of general practice
  • The health needs of individuals are balanced with the health needs of the community through effective utilisation of resources

D4. Professional and ethical role
  • Adherence to relevant codes and standards of ethical and professional behaviour

D5. Organisational and legal dimensions
  • Medico-legal requirements are integrated into accurate documentation

Curriculum Contextual Units

  • Adult health
  • Addiction medicine

Partnering organisations

The NSW Ministry of Health (Centre For Population Health); New South Wales Users and AIDS Association (NUAA).

Activity sponsor

The NSW Ministry of Health (Centre For Population Health).

Session summary

Date

Monday 22 Apr 2019 12:00am - Tuesday 31 Dec 2019 12:00am

This activity is readily available at any time

URL

www.drivingsafety.com.au

Delivery

E-learning

Hours

1

Attendees

All attendees welcome

Target Audience

GPs and practice team

For more information contact...

Daniel Winter
T: 02 9515 9811
E: otac.info@sydney.edu.au